"Grupo Neolpharma"

#12526025

3 July 2025

The CEO of Neolpharma Group, Luz Astrea Ocampo Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526026

3 July 2025

The CEO of Neolpharma Group, Luz Astrea Ocampo Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526027

3 July 2025

Executive Chairman of the Board of Neolpharma Group, Diego Antonio Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526015

3 July 2025

Mexico's Health Minister, David Kershenobich Stalnikowitz, and Mexico's Economic Minister, Marcelo Ebrard Casaubon, attend the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526016

3 July 2025

Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526017

3 July 2025

Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526018

3 July 2025

Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526019

3 July 2025

Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526020

3 July 2025

Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526021

3 July 2025

Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526022

3 July 2025

Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526023

3 July 2025

The CEO of Kener Laboratories, Federico Prince Laris, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526024

3 July 2025

The General Director of GENBIO, Jose Miguel Ramos Rodriguez, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526028

3 July 2025

Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526029

3 July 2025

Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12526030

3 July 2025

Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.